Alexander Roth

Dr. Alexander Roth

Orthopedics
33100 Cleveland Clinic Boulevard, 
Avon, OH 
On Staff At
33100 Cleveland Clinic Boulevard, 
Avon, OH 
OverviewInsuranceLocationsClinical Research

Overview

Alexander Roth is an Orthopedics provider in Avon, Ohio. Dr. Roth is rated as an Experienced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Bowlegs, Osteoarthritis, Osteotomy, and Knee Replacement.

His clinical research consists of co-authoring 122 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Cleveland Clinic
Specialties
Orthopedics
Licenses
Adult Reconstructive Orthopaedic Surgery in OH
Board Certifications
American Board Of Orthopaedic Surgery
Fellowships
Cleveland Clinic
Hospital Affiliations
Lutheran Hospital
Firelands Regional Medical Center
Cleveland Clinic Avon Hospital
Cleveland Clinic
Fairview Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Avon - Richard E. Jacobs Health Center
33100 Cleveland Clinic Boulevard, Avon, OH 44011
Other Locations
Sheffield Family Health Center
5334 Meadow Lane Court, Sheffield Village, OH 44035

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Open-label, Non-randomized, Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia
A Multicenter, Open-label, Non-randomized, Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia
Enrollment Status: Terminated
Publish Date: December 05, 2024
Intervention Type: Drug
Study Drugs: Isatuximab SAR650984, Diphenhydramine, Famotidine, Acetaminophen, Montelukast
Study Phase: Phase 2
A Phase 1 Safety, Tolerability, and Pharmacokinetics & Pharmacodynamics Study of Multiple- Dose BIVV009 in Patients With Chronic Immune Thrombocytopenia (ITP)
A Phase 1 Safety, Tolerability, and Pharmacokinetics & Pharmacodynamics Study of Multiple- Dose BIVV009 in Patients With Chronic Immune Thrombocytopenia (ITP)
Enrollment Status: Completed
Publish Date: May 18, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion
A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: October 31, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
International Post-Marketing Surveillance of Willfact-Wilfactin in Patients With Inherited Von Willebrand Disease.
Enrollment Status: Completed
Publish Date: August 08, 2018
View 4 Less Clinical Trials

124 Total Publications

Cold agglutinin disease (CAD)
Cold agglutinin disease (CAD)
Journal: Innere Medizin (Heidelberg, Germany)
Published: May 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roth's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile